Liraglutide, a GLP-1 agonist, has been reported to improve manic-like symptoms by enhancing hippocampal oxidation and brain-derived neurotrophic factor levels in a BD model induced by D-amphetamine [45]. The gene discussed is GLP1R; the disease is Behcet disease.